KeifeRx is an emerging clinical-stage biopharmaceutical company developing novel and optimized, low dose, orally delivered tyrosine kinase inhibitors (TKIs) for the treatment of multiple, high-need neurodegenerative and immune diseases.
| Website | https://www.keiferx.com/ |
| Employees | 7 (3 on RocketReach) |
| Founded | 2019 |
| Address | 1356 Beverly Rd 300, McLean, Virginia 22101, US |
| Phone | +1 703-790-5590 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+11 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Biopharmaceutical, Neurodegenerative Diseases, Targeted Therapy, Clinical Stage, Novel Therapies, Clinical Trials, Drug Development, Biotechnology, Pharmaceutical Research, Precision Medicine, Therapeutics, Disease Treatment |
| Competitors | CVS Health, UNITEDHEALTHCARE INSURANCE COMPANY, Walgreens, RITE AID, Scripps Health, Express Scripts, MedImpact Healthcare Systems, Inc., Optum Rx, PharmacyX, Humana Pharmacy, Inc. +30 more (view full list) |
Looking for a particular KeifeRx employee's phone or email?
KeifeRx Questions
Chris Hoyt is the CEO of KeifeRx.
3 people are employed at KeifeRx.
KeifeRx is based in McLean, Virginia.
Top KeifeRx Employees
-
Chris Hoyt
Chief Executive Officer at KeifeRx
Chantilly, VA, US25+ -
William Hoyt
Project Manager at KeifeRx
Morgantown, WV, US23 -
Martha Connolly
Corporate Advisor at KeifeRx
Baltimore, MD, US15
Related Companies
G2Crowd Trusted
300K+
Plugin Users
